StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)

Close on Nov 17, 2026Market cap $1.29MP/E –Yield –

Scinai Immunotherapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was -202.3%, against -88.1% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-202.3%−114.1
FY2024Dec 31, 2024-88.1%–

More Scinai Immunotherapeutics figures

See a number that looks wrong?